AR053132A1 - Sales de tartrato y de malato de trans-1-(6-cloro-3-fenilidan-1-il)-3,3-dimetilpiperazina - Google Patents

Sales de tartrato y de malato de trans-1-(6-cloro-3-fenilidan-1-il)-3,3-dimetilpiperazina

Info

Publication number
AR053132A1
AR053132A1 ARP060100518A ARP060100518A AR053132A1 AR 053132 A1 AR053132 A1 AR 053132A1 AR P060100518 A ARP060100518 A AR P060100518A AR P060100518 A ARP060100518 A AR P060100518A AR 053132 A1 AR053132 A1 AR 053132A1
Authority
AR
Argentina
Prior art keywords
trans
chloro
tartrate
fenilidan
dimethylipiperazine
Prior art date
Application number
ARP060100518A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38006636&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR053132(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR053132A1 publication Critical patent/AR053132A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones farmacéuticas que los contienen, usos para tratar esquizofrenia u otros síntomas psicoticos y método de preparacion. Reivindicacion 1: Una sal de malato del compuesto 1, donde el compuesto 1 (trans-1-((1R,3S)-6-cloro-3-fenilindan-1- il)-3,3-dimetilpiperazina) tiene la formula (1). Reivindicacion 9: Una sal de tartrato del compuesto 1, donde el compuesto 1 (trans-1-((1R,3S)-6-cloro-3-fenilindan-1-il)-3,3-dimetilpiperazina) tiene la formula (1).
ARP060100518A 2005-02-16 2006-02-14 Sales de tartrato y de malato de trans-1-(6-cloro-3-fenilidan-1-il)-3,3-dimetilpiperazina AR053132A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200500238 2005-02-16

Publications (1)

Publication Number Publication Date
AR053132A1 true AR053132A1 (es) 2007-04-25

Family

ID=38006636

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100518A AR053132A1 (es) 2005-02-16 2006-02-14 Sales de tartrato y de malato de trans-1-(6-cloro-3-fenilidan-1-il)-3,3-dimetilpiperazina

Country Status (7)

Country Link
KR (1) KR20070107043A (es)
CN (1) CN101119982A (es)
AR (1) AR053132A1 (es)
EA (1) EA200701737A1 (es)
IL (1) IL184531A0 (es)
TW (1) TW200640891A (es)
ZA (1) ZA200705461B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009135495A1 (en) * 2008-05-07 2009-11-12 H. Lundbeck A/S Method for treating cognitive deficits
TW201102370A (en) * 2009-07-07 2011-01-16 Lundbeck & Co As H Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl piperazine
JP2014501771A (ja) * 2011-01-07 2014-01-23 ハー・ルンドベック・アクチエゼルスカベット ４−（（１ｒ，３ｓ）−６−クロロ−３−フェニル−インダン−１−イル）−１，２，２−トリメチル−ピペラジンと１−（（１ｒ，３ｓ）−６−クロロ−３−フェニル−インダン，１−イル）−３，３−ジメチル−ピペラジンとを分割するための方法

Also Published As

Publication number Publication date
EA200701737A1 (ru) 2007-12-28
CN101119982A (zh) 2008-02-06
KR20070107043A (ko) 2007-11-06
IL184531A0 (en) 2007-10-31
ZA200705461B (en) 2008-09-25
TW200640891A (en) 2006-12-01

Similar Documents

Publication Publication Date Title
CL2012002526A1 (es) Uso de compuestos inhibidores de dpp iv de formula (i) o (ii) o una de sus sales, para el tratamiento de falla cardiaca.
GT200600420A (es) Sales novedosas de lisina de derivados de acido 4-((fenoxialquil)tio)-fenoxiacetico
EA200800514A1 (ru) Замещённые 7-азаиндазолы, содержащие их композиции, способ получения и применения
CO6511251A2 (es) Compuestos quimicos
UY28482A1 (es) Nuevos compuestos
AR056014A1 (es) Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo
ECSP088414A (es) Derivados de ácido bifeniloxiacético para el tratamiento de una enfermedad respiratoria
GT200600206A (es) Nuevos derivados del fluoreno, composiciones que los contienen y su utilizacion
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
CR10027A (es) Nuevos derivados de pirrol fusionado
DOP2002000392A (es) Sales tartrato de 5,8,14 triazatetraciclo [10.3.1.024 0.4.9] hexadeca-2 (11), 3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
DOP2006000170A (es) Nuevos derivados de espirocromanona
GT200800242A (es) Derivados biciclicos como inhibidores de cetp
UY29343A1 (es) Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso.
ECSP055853A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
BRPI0507903A (pt) derivados de quinazolina e composição farmacêutica compreendendo os mesmos
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
SE0502254L (sv) Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
AR079050A1 (es) Compuestos benzoimidazolicos y sus usos
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
AR059357A1 (es) Formulaciones farmaceuticas
AR078142A1 (es) Compuestos inhibidores heteroarilicos biciclicos de pde4, las composiciones farmaceuticas que los contienen y el uso de los mismos para la preparacion de medicamentos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure